Global Drug Discovery Services Market Outlook, Industry
Drug discovery can be described as the process of identifying potential new drugs and includes a wide range of scientific disciplines including biology, chemistry, and pharmacology. The drug discovery process includes several methods such as target molecule identification, candidate drug identification, characterization, screening, and therapeutic efficacy testing. Once a candidate compound has shown therapeutic value in these tests, it will begin the drug development process prior to clinical trials. it involves developing new antibodies, recombinant proteins, hormones, vaccines and gene therapy to treat cancer, neurological disorders, cardiovascular disorders and many more.
According to the research report, “Drug Discovery Services Market By Type (Medicinal Chemistry Services, Drug Biology, Pharmacokinetics and Metabolism Services), By Drug Type (Small Molecules, Biologics), By Therapeutic Area (Oncology , Neurological Disorders, Respiratory Diseases, Diabetes, Cardiovascular Diseases), by Regions (North America, Europe, Asia-Pacific, Rest of the World) – Global Forecast to 2025,” indicates that the market generates the majority of the revenue from major actors operating in this field; some of them are Charles River Laboratories, Evotec SE, GVK Biosciences, Albany Molecular Research Inc., Domainex Ltd., Genscript Biotech Corporation, Syngene International Ltd., Eurofins Scientific SE and Laboratory Corporation of America Holdings. The report includes profiling of each player mentioned above on the basis of parameters such as company overview, production capacity, revenue, key business offerings, financial performance, risk analysis, recent developments and regional presence. Along with these, it also provides insights through different research methodologies like Porter Five analysis and SWOT analysis. It further examines how well the player stands in the competition with reference to the intense competition among several players to gain a major share of the market.
For more information, refer to the link below:-
As stated above, the drug discovery services market is categorized into different segments. Within the Type category – the medicinal chemistry services sub-segment is projected for the major part and is expected to grow during the forecast period. Likewise, based on the therapeutic areas, oncology is expected to maintain its position throughout the forecast period. The study provides exclusive details about the sub-segment for better understanding of the global drug discovery services market. the study includes market reports for all the regions mentioned above along with the countries that these regions consist of. Additionally, the report also provides the market trends for the smart automation industry both in the present and the future.
The research report is provided with various dimensions such as market dynamics, historical data analysis and technological development, strategies adopted by the aforementioned companies, government initiatives for drug discovery services and the study market size (in terms of value and volume) based on demand and supply, market growth drivers, application details, market characteristics, restraints, growth opportunities, regional and sectoral investments and much more.
In the coming years, the Drug Discovery Services industry will continue to grow and is expected to reach a revenue value of Millions of US Dollars by the end of 2025 at a double-digit CAGR during the period. 2019-2025 exam. Rising number of patients with various chronic diseases and increasing technological advancements will improve the status of the drug discovery services market.
For more information, refer to the link below:-
Related reports: –
Ankur Gupta, Marketing and Communications Manager
Ken Research Pvt. Ltd.,
Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49 Gurgaon, Haryana – 122001, India
Ken Research is a research-based management consulting firm. We provide strategic advice to help clients on critical business insights: strategy, marketing, organization, operations and technology transformation, advanced analytics, corporate finance, mergers and acquisitions, and sustainability across all industries and geographies. We provide business intelligence services and operational advice in over 300 verticals highlighting disruptive technologies, emerging business models with analysis of precedents and success case studies. Some of the best consulting firms and market leaders seek our intelligence to identify new revenue streams, customer/vendor paradigm and pain points and competitive due diligence.
We currently serve over 300 industries with over 150,000 search repositories in over 196 countries serving over 1,000 clients and have partnered with nearly 25 content aggregators.
This press release was published on openPR.